Last reviewed: July 3, 2026

Last updated: July 3, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Wegovy (semaglutide) and Mounjaro (tirzepatide) both reduce appetite and support weight loss, but they target your body's hunger signals in distinct ways. While both medications belong to the GLP-1 family, tirzepatide adds a second receptor target that semaglutide does not engage, creating different outcomes for different patients.

How Semaglutide and Tirzepatide Work Differently

Semaglutide activates one receptor in your brain and gut called GLP-1R. This receptor signals fullness, slows stomach emptying, and reduces hunger cravings. Wegovy delivers semaglutide through weekly injections designed for weight management at higher doses than those used for diabetes control.

Tirzepatide, the active ingredient in Mounjaro, activates two receptors: GLP-1R and GIPR (glucose-dependent insulinotropic polypeptide receptor). By engaging both pathways simultaneously, tirzepatide may produce stronger appetite suppression and metabolic effects in some patients. Clinical trials show tirzepatide users lost more weight on average than semaglutide users at comparable timepoints.

Weight Loss Results: Clinical Evidence and Real-World Outcomes

Wegovy trials demonstrated approximately 15-22% body weight reduction over 68 weeks in people without diabetes. The STEP trials, which evaluated semaglutide for chronic weight management, enrolled thousands of participants and tracked sustained weight loss over nearly two years.

Mounjaro's tirzepatide showed approximately 21-27% body weight reduction in the SURMOUNT trials over a similar timeframe. These studies suggest tirzepatide may offer modestly greater weight loss, though individual results vary widely based on genetics, lifestyle, and adherence. Not every patient responds identically to either medication.

Genetic Factors That Influence Your Response to Weight Loss Therapy

Your DNA shapes how effectively semaglutide or tirzepatide will work for you. Variants in the GLP1R gene (rs6923761), GIPR gene (rs1800437), FTO gene (rs9939609), and MC4R gene (rs17782313) influence appetite regulation and metabolic rate. The PlexusDx Precision Peptide Genetic Test maps 14 pathways across 49 peptides to identify your genetic predispositions to weight gain and medication response.

Understanding your peptide genetics before starting treatment helps predict which compound—semaglutide or tirzepatide—may work best for your physiology. Some patients carry genetic variants that enhance tirzepatide's dual-receptor mechanism, while others respond equally well to single-receptor semaglutide. Precision testing removes guesswork from medication selection.

Cost, Access, and Convenience: PlexusDx Compounded Options

Branded Wegovy and Mounjaro carry significant out-of-pocket costs, often ranging from $900 to $1,500 monthly without insurance coverage. PlexusDx offers compounded semaglutide injection starting at $149 per month and compounded tirzepatide injection starting at $249 per month—flat pricing with no dose-based increases. These medications come from licensed 503A compounding pharmacies and serve all 50 states without membership fees.

PlexusDx also offers oral semaglutide ($249/mo) and oral tirzepatide ($279/mo) for patients who prefer not to inject. All formulations are HSA and FSA eligible. The Precision Peptide Genetic Test costs $99 as an add-on after your first month of treatment, providing personalized insights to optimize your long-term therapy.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is Wegovy or Mounjaro more effective for weight loss?

Clinical trials show tirzepatide (Mounjaro) produced slightly greater average weight loss than semaglutide (Wegovy), but both are highly effective. Individual results depend on genetics, adherence, diet, and exercise. PlexusDx's Precision Peptide Genetic Test can identify which mechanism may work best for your specific genetic profile.

What are the main side effects of semaglutide versus tirzepatide?

Both medications commonly cause nausea, particularly at dose initiation, which typically improves over time. Tirzepatide users report slightly higher rates of nausea in trials, but serious side effects are rare. Gastrointestinal effects, appetite suppression, and mild fatigue are expected responses as your body adjusts to appetite regulation.

Can I switch from Wegovy to Mounjaro or vice versa?

Yes, switching between semaglutide and tirzepatide is medically feasible and sometimes recommended if one compound isn't delivering desired results. PlexusDx providers can discuss transition protocols and help identify which medication aligns better with your genetic predispositions and personal weight loss goals.

How much does PlexusDx compounded tirzepatide cost?

PlexusDx compounded tirzepatide injection starts at $249 per month with flat pricing regardless of dose. Your dose may increase over time, but your monthly price remains fixed. The medication is prepared by licensed 503A compounding pharmacies, is available in all 50 states, and is HSA/FSA eligible with no membership required.

What does the PlexusDx Precision Peptide Genetic Test reveal?

The test analyzes 14 metabolic pathways, 49 peptides, and 150+ genetic insights including variants in GLP1R, GIPR, FTO, and MC4R genes. These results predict your appetite regulation capacity, metabolic predispositions, and likely response to semaglutide versus tirzepatide therapy. Testing costs $99 after your first treatment month.

Related Reading

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves